Stock A003090 DAEWOONG CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Daewoong Co., Ltd.

Equities

A003090

KR7003090008

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 20/05/2024 BST 		5-day change 1st Jan Change
18,300 KRW -1.82% Intraday chart for Daewoong Co., Ltd. -4.69% -11.38%
04-24 Korean Sugar Imports Plunge 14% as Diabetes Cases Surge MT
03-08 Daewoong Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Daewoong Co Ltd is a Korea-based holding company engaged in the manufacture and sale of pharmaceuticals. The Company operates its business mainly through subsidiaries including Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd, Daewoong Development Co Ltd, and Hanall Biopharma Co Ltd. Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd and Hanall Biopharma Co Ltd are engaged in the manufacture and sale of pharmaceuticals. Daewoong Development Co Ltd is engaged in real estate rental and supply business. In addition, IDS&Trust Co Ltd manufactures and sells communication-related devices. Daewoong Life Science Co Ltd is engaged in food processing and sales. Pampaeg Co Ltd is engaged in the packaging business of quasi-drugs. Daewoong Management Development Institute Co Ltd is engaged in management and industrial training projects.

Number of employees: 348

Sales per Business

KRW in Million2022Weight2023Weight Delta
Pharmaceutical
108.1 %
1,832,140 107.9 % 1,961,127 108.1 % +7.04%
Consolidation Adjustment
-15.5 %
-246,498 -14.5 % -281,032 -15.5 % +14.01%
Service
6.3 %
96,960 5.7 % 114,120 6.3 % +17.70%
Real Estate Lease
0.6 %
6,308 0.4 % 10,863 0.6 % +72.21%
Others
0.5 %
8,428 0.5 % 8,763 0.5 % +3.97%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
76.7 %
1,701,044 100.2 % 1,390,446 76.7 % -18.26%
International
38.8 %
242,792 14.3 % 704,428 38.8 % +190.14%
Consolidation Adjustment
-15.5 %
-246,498 -14.5 % -281,032 -15.5 % +14.01%

Managers

Managers TitleAgeSince
Jae-Chun Yoon CEO
 Chief Executive Officer 64 31/07/85
Chang-Jae Lee BRD
 Director/Board Member 47 30/11/02
Woo-Bang Jeon AUD
 Comptroller/Controller/Auditor 63 -

Members of the board

Members of the board TitleAgeSince
Young-Cheol Kang BRD
 Director/Board Member 67 28/03/22
Jae-Chun Yoon CEO
 Chief Executive Officer 64 31/07/85
Geon-Haeng Lee BRD
 Director/Board Member 63 -
Chang-Jae Lee BRD
 Director/Board Member 47 30/11/02
Jong-Guk Kim BRD
 Director/Board Member 63 28/02/18
Hoon-Seok Lee BRD
 Director/Board Member 59 28/03/22

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 58,141,980 18,563,270 ( 31.93 %) 17,251,270 ( 29.67 %) 31.93 %

Shareholders

NameEquities%Valuation
DAEWOONG CO., LTD.
28.48 %
16,560,640 28.48 % 226 M ₩
Jae-Seung Yoon
11.87 %
6,902,660 11.87 % 94 M ₩
Daewoong Endowment Foundation
9.980 %
5,802,425 9.980 % 79 M ₩
Jae-yong Yoon
6.974 %
4,054,715 6.974 % 55 M ₩
Young Yoon
5.423 %
3,153,310 5.423 % 43 M ₩
National Pension Service of Korea
3.996 %
2,323,613 3.996 % 32 M ₩
Insung T.S.S Co., Ltd.
1.771 %
1,029,430 1.771 % 14 M ₩
DN Company Co., Ltd.
1.771 %
1,029,425 1.771 % 14 M ₩
Daewoong Co., Ltd. Employee Stock Ownership Association
0.3116 %
181,158 0.3116 % 2 M ₩
Bong-ae Chang
0.1112 %
64,625 0.1112 % 879 996 ₩

Holdings

NameEquities%Valuation
DAEWOONG PHARMACEUTICAL CO., LTD
52.29%
 6,058,200 52.29% 490,494,590 $
DAEWOONG CO., LTD.
28.48%
 16,560,640 28.48% 225,505,572 $
AEON BIOPHARMA, INC.
17.41%
 6,577,604 17.41% 27,954,817 $
BRIDGE BIOTHERAPEUTICS, INC.
1.01%
 246,240 1.01% 415,121 $

Company contact information

Daewoong Co., Ltd.

244 Galmachi-ro Jungwon-gu

13211, Seongnam

+

http://www.daewoongholdings.com
address Daewoong Co., Ltd.(A003090)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Ratings for Daewoong Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
18,300 KRW
Average target price
25,000 KRW
Spread / Average Target
+36.61%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
DAEWOONG CO., LTD. Stock Daewoong Co., Ltd.
-11.38% 549M
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+20.08% 22.46B
SANDOZ GROUP AG Stock Sandoz Group AG
+18.14% 15.04B
CIPLA LIMITED Stock Cipla Limited
+18.94% 13.98B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+56.80% 13.15B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.55% 6.89B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+14.03% 5.71B
RICHTER GEDEON VEGYÉSZETI GYÁR NYILVÁNOSAN MUKÖDO RT. Stock Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
+6.11% 4.69B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A003090 Stock
  4. Company Daewoong Co., Ltd.